Basic Information
| LncRNA/CircRNA Name | LINC00460 |
| Synonyms | NA |
| Region | GRCh38_13:106374477-106384315 |
| Ensemble | ENSG00000233532 |
| Refseq | NR_034119 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | bladder cancer |
| ICD-0-3 | C67 |
| Methods | qPCR |
| Sample | bladder cancer tissues,cell lines(5637,T24,J82, TCCSUP, UM-UC-3 and SV-HUC-1) |
| Expression Pattern | up-regulated |
| Function Description | it was identified that LINC00460 was highly upregulated compared with the normal adjacent tissue. |
| Pubmed ID | 30881506 |
| Year | 2019 |
| Title | The long non-coding RNA LINC00460 predicts the prognosis and promotes the proliferation and migration of cells in bladder urothelial carcinoma. |
External Links
| Links for LINC00460 | GenBank HGNC NONCODE |
| Links for bladder cancer | OMIM COSMIC |